Last reviewed · How we verify
Metal Panel T.R.U.E. Test — Competitive Intelligence Brief
phase 3
Dermatology
Biologic
Live · refreshed every 30 min
Target snapshot
Metal Panel T.R.U.E. Test (Metal Panel T.R.U.E. Test) — Allerderm. Metal Panel T.R.U.E. Test is a diagnostic patch test system that identifies contact allergies to metals by measuring delayed-type hypersensitivity reactions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Metal Panel T.R.U.E. Test TARGET | Metal Panel T.R.U.E. Test | Allerderm | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Metal Panel T.R.U.E. Test CI watch — RSS
- Metal Panel T.R.U.E. Test CI watch — Atom
- Metal Panel T.R.U.E. Test CI watch — JSON
- Metal Panel T.R.U.E. Test alone — RSS
Cite this brief
Drug Landscape (2026). Metal Panel T.R.U.E. Test — Competitive Intelligence Brief. https://druglandscape.com/ci/metal-panel-t-r-u-e-test. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing